TCTMD - tctmd.com
WEBGiven the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart ...
TCT 2024 - TCTMD.com
WEBTCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Blood Pressure Insights in COVID-19: Watch for Drops and RAAS …
WEBSep 10, 2020 · Here, Baher Al-Abbasi, MD (University of Miami/JFK Medical Center, Atlantis, FL), and colleagues noted increased in-hospital mortality in 172 COVID-19 patients taking ACE inhibitors or ARBs compared with those not taking the drugs (33% vs 13%; P = 0.003), as well as increased likelihood of admission to the …
More Trial Evidence Supports Tenecteplase for Acute Stroke …
WEBMay 21, 2024 · Later in the meeting, Shuya Li, MD (Beijing Tiantan Hospital, Capital Medical University, China), presented the results of the ORIGINAL trial, a phase III study designed to support regulatory approval of tenecteplase for acute stroke in China. At 55 sites across the country, investigators randomized 1,489 patients (mean age 65 …
Slides | tctmd.com
WEBApr 8, 2024 · Interventional Complications 2023. Seattle, WA. July 14. July 15, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
Welcome to TCTMD | tctmd.com
WEBOn behalf of CRF and TCTMD, we would like to extend a warm welcome to our community, which has developed over the past 20 years around a common goal to improve the survival and quality of life for people living with cardiovascular disease through research and education. We look forward to seeing you at our conferences and to working together to ...
‘Landmark Moment’ for Middle Meningeal Artery ... - TCTMD.com
WEBFeb 16, 2024 · PHOENIX, AZ—Middle meningeal artery (MMA) embolization with liquid agents looks set to become the standard of care for the treatment of nonacute subdural hematoma after three randomized trials reported a week ago at the International Stroke Conference (ISC) demonstrated the procedure’s benefits. All …
No Fasting Before PCI? Study Shows No Harm—and Happier …
WEBJan 16, 2024 · On a score of 1 to 5, with 1 being most satisfied with their diet before the procedure, the mean score was 1.3 in the group who did not fast versus 3.1 for those who did fast (P < 0.001). As a group, those allowed to eat reported less thirst before the procedure and less hunger before and after the procedure than those in …
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
WEBAug 28, 2024 · Now, according to the manufacturer, it will also be available in 2.5-mg and 5-mg single-dose vials at a cost that’s at least 50% lower than the other GLP-1 drugs on the market. Specifically, 4-week supplies of the 2.5-mg and 5-mg single-dose vials are priced at $399 and $549, respectively. According to GoodRx, the retail price for four ...
New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides
WEBAug 21, 2019 · For managing hypertriglyceridemia (200-499 mg/dL), the AHA experts state that prescription-strength omega-3 fatty acids, either with eicosapentaenoic acid (EPA) or EPA plus docosapentaenoic acid (DHA), would be expected to yield a 20% to 30% reduction in triglycerides without any increase in LDL cholesterol.